SGLT2抑制剂治疗2型糖尿病的研究进展
被引量:1
摘要
随着糖尿病患病率的迅猛增加和控制达标率的不满意,糖尿病的治疗引起广泛关注。传统口服降血糖药物的作用机制多样,但目前上市的药物中没有一种药物是通过增加葡萄糖的排泄从而达到降血糖作用的。肾脏在人体代谢平衡的维持及血糖的调控中起着重要的作用。在健康成人中,每天大概有180g的葡萄糖从肾小球滤过,
出处
《重庆医学》
CAS
CSCD
北大核心
2013年第17期2024-2027,共4页
Chongqing medicine
参考文献23
-
1Neumiller JJ,White JR,Campbell RK.Sodium-glucose co-transport inhibitors:progress and therapeutic potential intype 2 diabetes mellitus[J].Drugs,2010,70(4):377-385.
-
2Debnam ES,Unwin RJ.Hyperglycemia and intestinal andrenal glucose transport:implications for diabetic renal in-jury[J].Kidney Int,1996,50(4):1101-1109.
-
3Uldry M,Thorens B.The SLC2 family or facilitated hex-ose and polyol transporters[J].Pflugers Arch,2004,447(5):480-489.
-
4Wright EM,Turk E.The sodium/glucose cotransport familySLC5[J].Pflugers Arch,2004,447(5):510-518.
-
5Wright EM,Hirayama BA,Loo DF.Active sugar trans-port in health and disease[J].J Intern Med,2007,261(1):32-43.
-
6Wright EM.Renal Na(+ )-glucose cotransporters[J].AmJ Physiol Renal Physiol,2001,280(1):10-18.
-
7Kanai Y,Lee WS,You G,et al.The human kidney low af-finity Na +/glucose cotransporter SGLT2.Delineation ofthe major renal reabsorptive mechanism for I>glucose[J].J Clin Invest,1994,93(3):397-404.
-
8van den Heuvel LP,Assink K,Willemsen M,et al.Auto-somal recessive renal glucosuria attributable to a mutationin the sodium glucose cotransporter(SGLT2 )[J].HumGenet,2002,lll(6):544-547.
-
9Francis J,Zhang J,Farhi A,et al.A novel SGLT2 muta-tion in a patient with autosomal recessive renal glucosuria[J].Nephrol Dial Transplant,2004,19(11):2893-2895.
-
10Dudosh J,Zhang X,Zeck RE,et al.Glycooylated dihydroehal-cones as potent and selective sodium glucose co-transport-ers 2(SGLT2 )inhibitors [ J],Bioorg Med Chem Lett,2004,14(20):5121-5125.
同被引文献13
-
1TAHRAN,ANTHONY H B,CLIFFORD J B.SGLT inhibitors in management of diabetes[J].Lancet Diabetes Endorinol,2013,1(2):140-151.
-
2FARHAD M,HMAZEN A,JOHN E G.SGLT2 inhibitors in the treatment of type 2 diabetes[J].Diabetse Res Clin Pr,2014,104(3):297-322.
-
3BRIAN Z,IKE O,KENNY F,et al.Effects of LX4211,a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor,on postprandial glucose,insulin,glucagon-like peptide 1,and peptide tyrosine tyrosine in a dose-timing study in healthy subjects[J].Clin Ther,2013,35(8):1162-1173.
-
4GOODWIN N C,HARRISON B A,ⅡMURA S,et al.M ethods and compounds useful for the preparation of sodium glucose co-transporter 2 inibitors:WO,2009014970[P].2009-01-29.
-
5LIDIA D L,GIAMPAOLO G,SIMONETTA M,et al.Trichloroisocyanuric/TEM PO oxidation of alcohols under mild conditions:a close investigation[J].J Org Chem,2003,68(12):4999-5001.
-
6FARID M I,KONSTANTIN A S,JANNE V J,et al.Reaction of 1,2-trans-glycosyl acetates w ith thiourea:a new entry to 1-thiosugars[J].Tetrahedron Lett,2003,44(43):7961-7964.
-
7TADASHI H,HIROKI B,HIROKI T,et al.Synthetic studies on pterin glycosides:the first synthesis of 2'-O-(α-D-glucopyranosyl)biopterin[J].Tetrahedron,2009,65(38):7989-7997.
-
8尼克勒·C·古德温,布赖斯·A·哈里森,斯彭尼尔·D·金博尔,等.钠-葡萄糖协同转运蛋白2的抑制剂及其用法:中国,101343296B[P].2013-04-10.
-
9OSAMU M,KAZUYA Y,HIDEO T,et al.Synthesis and biological evaluation of deoxy salacinols,the role of polar substituents in the side chain on theα-glucosidase inhibitory activity[J].Bioorg M ed Chem,2006,14(2):500-509.
-
10CHRISTIAN A,MONTALBETTI C A G N,FALQUE V.Amide bond formation and peptide coupling[J].Tetrahedron,2005,61(46):10827-10852.
-
1陈燕梅,李志勇.达格列净的临床应用进展[J].重庆医学,2013,42(34):4214-4216. 被引量:5
-
2付丽坤,姜晓艳.SGLT2抑制剂治疗2型糖尿病的相关研究[J].国际内分泌代谢杂志,2012,32(2):84-86. 被引量:1
-
3徐鸽,沈玫,吕彬华,许百华,李绍顺.2型糖尿病治疗新靶点SGLT2抑制剂的研究进展[J].现代生物医学进展,2009,9(13):2569-2572. 被引量:8
-
4张琳(译),王海宁(校),洪天配(校).从苹果树皮的根皮苷到钠-葡萄糖协同转运蛋白(SGLT)抑制剂--SGLT2抑制剂研发的历史与现状[J].中国糖尿病杂志,2011,19(1):76-77. 被引量:3
-
5刘宇翔,李代清.SGLT2抑制剂治疗2型糖尿病的临床研究[J].国际内分泌代谢杂志,2016,36(5):327-330. 被引量:2
-
6求求.SGLT2抑制剂可致非典型糖尿病酮症酸中毒[J].中华医学信息导报,2016,0(4):7-7.
-
7二甲双胍仍为2型糖尿病一线治疗药物[J].家庭健康(医学科普),2016(6):5-5.
-
8本刊2011年第6期部分文题介绍[J].国际内分泌代谢杂志,2011,31(5):342-342.
-
9邓大同,杨明功.SGLT2抑制剂:从尿降糖的降糖药[J].糖尿病之友,2009(4):48-48.
-
10朱蕾,杨怡.钠-葡萄糖协同转运蛋白与糖尿病[J].国际内分泌代谢杂志,2011,31(6):406-408. 被引量:2